This is a working overview of anxiolytic, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.
Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | Modeled on tuftsin |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Seven residues |
| Approximate molecular mass | Around 750 Da | Depends on counter-ion and hydration |
| Common forms | Lyophilized powder | Also described as aqueous solution |
| Primary origin of research | Russian laboratories | Mid-1990s onward |
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Reported pharmacological effects center on reduced anxiety-like behavior in animal models and on measures of memory and learning. Proposed contributing mechanisms include modulation of GABAergic signaling, shifts in monoamine turnover, and changes in the activity of enzymes that degrade neuropeptides. Effects on the expression of genes linked to neuroplasticity have also been described. No single molecular target is widely accepted, and whether the behavioral findings arise from one pathway or several remains an open question.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
=== Target identification by chromatographic co-elution (TICC) === Target identification by chromatographic co-elution does not rely on differences in protein stability after drug treatment. Instead, it rests on the assumption that drugs form stable complexes with their target proteins, and that those complexes are robust enough to survive a chromatographic separation. In a typical workflow, a cell lysate is incubated with a drug, then the lysate is injected onto an ion-exchange chromatography system and fractionated. Lysate proteins are eluted along an ionic strength gradient and fractions are collected over short time intervals. Each fraction is analyzed by LC-MS/MS for both protein and drug content. Individual proteins elute with characteristic profiles, and pre-incubated drugs should mirror the elution profiles of the targets they complex with. Correlation of drug and protein elution profiles allows for targets to be narrowed down and inferred.
==== STS-118 ==== Caldwell Dyson was assigned to STS-118 on May 17, 2006. It was announced that she would serve as mission specialist 1 on the first flight of Space Shuttle Endeavour after the Columbia disaster. On August 8, 2007, Caldwell Dyson lifted off for the first time on the 119th Space Shuttle flight, the 22nd flight to the station, and the 20th flight for Endeavour. During the mission, she successfully added another truss segment, a new gyroscope and external spare parts platform to the International Space Station. A new system that enables docked shuttles to draw electrical power from the station to extend visits to the outpost was activated successfully. A total of four spacewalks (EVAs) were performed by three crew members. Endeavour carried some 5,000 pounds of equipment and supplies to the station and returned to Earth with some 4,000 pounds of hardware and no-longer-needed equipment. Traveling 5.3 million miles in space, the STS-118 mission was completed in 12 days, 17 hours, 55 minutes and 34 seconds. On day 7 of the flight of STS-118, Caldwell-Dyson celebrated her 38th birthday.
Bill Gates said that criticizing pharmaceutical company pricing deterred them from investing in medicines for the developing world, and said that instead, pharmaceutical companies should be praised for price discrimination which reduces the price in poor countries. He also advocated improving low-temperature supply chains (a.k.a. cold chains) in developing countries. In August 2019, MSF asked Gavi to stop giving Advance Market Commitment subsidies to GSK and Pfizer, whom they called a duopoly, and instead buy vaccine from a new third manufacturer, the Serum Institute of India, which offered the vaccine at 2/3 of the price then offered by the two. As the pneumococcal vaccine made up 40% of Gavi's vaccine purchasing costs, a 33% price drop would save Gavi billions (13% of its total vaccine purchasing costs). Pneumonia kills more than a quarter of children dying before the age of five, almost a million children each year. MSF said that GSK and Pfizer's pricing was exploitative and had left millions of children who could have been protected vulnerable. Gavi responded that low prices required large, stable, high-volume deals, and "careful consideration and the support of key constituencies". In June 2020, under Gavi's Advance Market Commitment, UNICEF and the Serum Institute of India entered an agreement which reduced the price of pneumococcal conjugate vaccines to $2 per dose.
City Manager's office Finance Department Human Resources Department Information Technology Department Municipal Court Parks and Recreation administrative staff Public Works Engineering, Building and Planning divisions. The city provides its own fire department, police department, library system, and also provides both their own water supply and wastewater treatment through the Public Works Operations division. The current wastewater treatment plant was completed in 2009. In total the local government employs around 450 full- and part-time employees with the majority in Police, Fire, and Public Works Operations. The Albany city government was nationally recognized in 2009 and 2010 with the Certificate of Distinction and in 2011 and 2012 with the Certificate of Excellence from the International City/County Management Association (ICMA) for its dedication to improving governmental performance. In 2010, 2011 and 2012, the Sunshine Review awarded Albany an A+ perfect score for government transparency and online accessibility with its website along with other government agencies from around the country. Also in September 2010, the League of Oregon Cities awarded Albany the Good Governance Award for the "Where Does My Money Go? and Albany Dashboard" web applications and featured Albany for governmental transparency. In January 2011, Government Computer News cited Albany as one of ten "Top Public Sector Websites" in the nation for government transparency.
A smart insulin patch, also known as a glucose-responsive insulin patch, is a type of wearable medical device for diabetes treatment. It is a transdermal patch comprising glucose-sensitive microneedle-array loaded with insulin for blood glucose regulation. Once applied on the skin, the microneedles penetrate under the skin and can sense blood sugar levels. If glucose levels go up, it can promote the release of insulin, which is transported through the regional lymph and capillary vessels for glucose regulation.
Sources: en.wikipedia.org
Palominos have a chestnut base coat color that is genetically modified to a golden shade by a single copy of the incomplete dominant cream gene. Palominos can be distinguished from chestnuts by the lack of true red tones in the coat; even the palest chestnuts have slight red tints to their hair rather than gold. The eyes of chestnuts are usually dark brown, while those of a palomino are sometimes a slightly lighter amber. Some color breed registries that promote palomino coloring have accepted flaxen chestnuts because registration is based on a physical description rather than a genetic identity. Cremellos have a chestnut base coat and homozygous (two copies) for the cream gene. They have a cream-colored coat, blue eyes and lightly pigmented pink skin. Red duns have a chestnut base coat with the dun gene (one or two copies). Their body color is pale, dusty tan shade that resembles the light undercoat color of a body-clipped chestnut but with a bold, dark dorsal stripe in dark red, a red mane, tail and legs. They may have additional primitive markings, which distinguish a red dun from a light or body-clipped chestnut. Gold champagnes have a chestnut base coat with the champagne gene (one or two copies). They resemble a palomino, or they may be an all-over apricot shade, but can be distinguished from other colors by amber or green eyes and lightened skin color with freckling. Red or "strawberry" roans have a chestnut base coat with the classic roan gene (one or two copies). A skewbald, "chestnut pinto" or "sorrel Paint" is a pinto horse with chestnut and white patches.
Raw veneer has no backing on it and can be used with either side facing up. The two sides will appear different when a finish has been applied due to the cell structure of the wood. Paper backed veneer is as the name suggests, veneers that are backed with paper. The advantage to this is it is available in large sizes, or sheets, as smaller pieces are joined prior to adding the backing. This is helpful for users that do not wish to join smaller pieces of raw veneers together. This is also helpful when veneering curves and columns as the veneer is less likely to crack. Phenolic backed veneer is less common and is used for composite, or artificial wood veneers. Due to concern for the natural resource, this is becoming more popular. It too has the advantage of being available in sheets, and is also less likely to crack when being used on curves. Laid up veneer is raw veneer that has been joined to make larger pieces. The process is time-consuming and requires great care, but is not difficult and requires no expensive tools or machinery. Veneers can be ordered through some companies already laid up to any size, shape or design. Reconstituted veneer is made from fast-growing tropical species. Raw veneer is cut from a log, and dyed if necessary. Once dyed, the sheets are laminated together to form a block. The block is then sliced so that the edges of the laminated veneer become the “grain” of the reconstituted veneer. Wood on Wood Also called 2-ply is a decorative wood veneer face with a utility grade wood backer applied at an opposing direction to the face veneer.
The unidirectionality of the system is a result from both the asymmetric skew of the helicene moiety as well as the strain of the cyclic urethane which is formed in c. This strain can be only be lowered by the clockwise rotation of the triptycene rotor in d, as both counterclockwise rotation as well as the inverse process of d are energetically unfavorable. In this respect the preference for the rotation direction is determined by both the positions of the functional groups and the shape of the helicene and is thus built into the design of the molecule instead of dictated by external factors.
After a slow start in the final's first two events, after which he found himself 7 points behind the leader in seventh place, he proceeded to dominate the rest of the event with five first place finishes in a row in the final five disciplines, winning the title with an event to spare. In the 2006 World's Strongest Man contest, despite starting the final well, he eventually came second to Phil Pfister after the American won the final five events in a row. Pudzianowski regained his title in 2007, winning the final with one event to spare for a record-breaking third time. In so doing, he joined Jon Pall Sigmarsson and Magnus Ver Magnusson as the only men to win the competition four times. During the 2007 competition, however, Pudzianowski said that his target was to become the only person to win the event five times, and he returned to the 2008 World's Strongest Man the following year to try to achieve his goal. Despite a serious calf injury suffered in the Polish Strongman Championship Cup of 2008 and further exacerbated during the WSM qualifying rounds, Pudzianowski still managed to win his heat and qualify for the final. However, it was clear his dominance of previous years was no longer in effect, as he only won one of the first five events in the final, and finished in fifth in two others. Trailing leader Derek Poundstone with two events to go, Pudzianowski managed to win the Plane Pull despite his injured calf to cut the deficit to just 1 point going into the final event.
Sources: en.wikipedia.org
Selank is a synthetic peptide made of seven amino acids. It is modeled on tuftsin, a natural tetrapeptide, with an added three-residue tail. It is not a small-molecule drug.
It originates from research in Russia, associated with the Institute of Molecular Genetics of the Russian Academy of Sciences. The first descriptions date to the mid-1990s. Most published studies come from Russian laboratories.
No, Selank itself does not occur naturally. Its backbone is based on tuftsin, which is produced in the body, but the seven-residue version is a synthetic construct. It is supplied as a manufactured peptide.
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.